Glioblastoma Foundation to Be Official Charity Partner of the 2024 Los Angeles Marathon

DURHAM, NC / ACCESSWIRE / March 14, 2024 / The Glioblastoma Foundation is proud to be a charity partner for the 2024 Los Angeles Marathon for the 5th year. The mission of the Glioblastoma Foundation is to transform glioblastoma therapy through funding research for new, more effective treatments for glioblastoma. Runners for Team Glioblastoma Foundation are accelerating our mission to transform glioblastoma from terminal to treatable!

“We are proud to be a charity partner of the Los Angeles Marathon for the 5th straight year. The Los Angeles Marathon provides a unique and powerful platform for us to spread awareness and raise funds to support clinical trials for the research of new drugs and other therapies for glioblastoma,” said Gita Kwatra, PharmD and Chief Executive Officer of the Glioblastoma Foundation.

On March 17th, the 26.2-mile marathon course will start at Dodger Stadium and will continue through Downtown Los Angeles, Little Tokyo, Hollywood, Rodeo Drive and more before finishing at Historic Route 66. The Finish Festival awaits all runners at Century Park!

Drs. Alexander Himstead and Gianna Fote, neurosurgery residents at University of California Irvine, are proud to be a part of Team Glioblastoma Foundation in the 2024 Los Angeles Marathon. “As neurosurgery residents, we see a tremendous number of patients and families affected by glioblastoma,” Dr. Himstead explained, and that’s why, “Gianna and I are running the LA marathon to raise research funds for the Glioblastoma Foundation.”

Glioblastoma is the most common and most deadly form of brain cancer, with an overall five-year survival rate of just seven percent. Each year, over 15,000 people are diagnosed with glioblastoma, and half of those diagnosed pass away within one year.

“The current standard of care for glioblastoma falls short. Every contribution, big or small, brings us closer to finding a cure for glioblastoma,” explained Kwatra.

To learn more about the Glioblastoma Foundation’s research initiatives and how you can get involved, visit https://glioblastomafoundation.org and follow the Glioblastoma Foundation on Facebook, Instagram, Twitter, and YouTube. Email info@glioblastomafoundation.org for additional information.

About Glioblastoma Foundation

Glioblastoma Foundation, Inc. is a national 501(c)(3) nonprofit charitable foundation headquartered in Durham, North Carolina. As the leading national organization dedicated to funding new, more effective treatments for glioblastoma, our mission is to improve the standard of care for this disease and support research that will transform glioblastoma into a manageable chronic condition.

Contact Information

Lucy Collins
Video Journalist
lucy@glioblastomafoundation.org
919-402-1775

SOURCE: Glioblastoma Foundation

View the original press release on newswire.com.

Staff

Recent Posts

Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial

Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…

2 hours ago

Modular Medical Announces Pricing of $8.2 Million Public Offering

SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…

5 hours ago

Nicole Garrett and Under Pressure Hyperbarics Lead the Charge in Wellness Education With Immersive Events at L.A. Fashion Weekend and Beyond

BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…

8 hours ago

Beacon Healthcare Systems Expands Leadership Team with Addition of Ayman Mohamed as Chief Technology Officer

HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…

11 hours ago

Talkiatry Ranked Number 6 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…

11 hours ago

Bright Light Imaging Leverages Alpha Nodus’s Gravity Auth, Enhanced by Integration with ADS’s MedicsRIS, to Streamline Patient Care

Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…

11 hours ago